Skip to main content

Flagship Pioneering, LLC's Form 4 filing

Omega Therapeutics, Inc. (OMGA) · filed Aug 5, 2021

Accession no.
0000899243-21-031797
Filed
Aug 5, 2021, 5:43 PM ET
Trade date
Aug 3, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 9 non-derivative transactions and 11 derivative transactions. Open-market purchases total $20.0M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Flagship Pioneering, LLCCIK 000140024010% Owner
Flagship Ventures Fund V, L.P.CIK 000162763910% Owner
Flagship Ventures Fund V General Partner LLCCIK 000172457510% Owner
Flagship V VentureLabs Rx Fund, L.P.CIK 000172493910% Owner
Flagship VentureLabs V LLCCIK 000172495910% Owner
Flagship VentureLabs V Manager LLCCIK 000176898710% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 3, 2021Common StockCConversionAcquired+1,088,470––1,088,470IndirectDuplicate filing
Aug 3, 2021Common StockCConversionAcquired+5,896,386––5,896,386IndirectDuplicate filing
Aug 3, 2021Common StockCConversionAcquired+8,396,825––8,396,825IndirectDuplicate filing
Aug 3, 2021Common StockPPurchaseAcquired+220,588$17.00+$3,749,9968,617,413IndirectDuplicate filing
Aug 3, 2021Common StockCConversionAcquired+970,588––970,588IndirectDuplicate filing
Aug 3, 2021Common StockCConversionAcquired+4,852,943––4,852,943IndirectDuplicate filing
Aug 3, 2021Common StockPPurchaseAcquired+661,764$17.00+$11,249,9885,514,707IndirectDuplicate filing
Aug 3, 2021Common StockCConversionAcquired+1,323,529––1,323,529IndirectDuplicate filing
Aug 3, 2021Common StockPPurchaseAcquired+294,117$17.00+$4,999,9891,617,646IndirectDuplicate filing

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 3, 2021Common StockCConversionDisposed−1,088,470––0IndirectDuplicate filing
Aug 3, 2021Common StockCConversionDisposed−5,896,386––0IndirectDuplicate filing
Aug 3, 2021Common StockCConversionDisposed−7,249,767––0IndirectDuplicate filing
Aug 3, 2021Common StockCConversionDisposed−794,118––0IndirectDuplicate filing
Aug 3, 2021Common StockCConversionDisposed−705,882––0IndirectDuplicate filing
Aug 3, 2021Common StockCConversionDisposed−176,470––0IndirectDuplicate filing
Aug 3, 2021Common StockCConversionDisposed−3,529,413––0IndirectDuplicate filing
Aug 3, 2021Common StockCConversionDisposed−882,353––0IndirectDuplicate filing
Aug 3, 2021Common StockCConversionDisposed−441,176––0IndirectDuplicate filing
Aug 3, 2021Common StockCConversionDisposed−1,323,530––0IndirectDuplicate filing
Aug 3, 2021Common StockCConversionDisposed−441,176––0IndirectDuplicate filing

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)